Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-08

Clinical Trial Update: Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating an adsorbed, three-component cell-free diphtheria-tetanus vaccine for prevention of pertussis, diphtheria, and tetanus; recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine

Snippet

Sponsor: Changchun BCHT Biotechnology Co. | Conditions: Prevent Whooping Cough, Prevent Diphtheria | Phase 3 | Status: RECRUITING